Jan 31, 2020 06:50AM

Oct 21, 2019 05:10PM

Feb 1, 2018 09:09AM

Jul 19, 2017 06:57AM

Apr 28, 2017 07:00AM

Mar 29, 2017 09:31AM

Mar 29, 2017 06:25AM Baird Reiterates Outperform Rating and $115 PT on Vertex Pharma (VRTX) Following Positive Tezacaftor/Ivacaftor Combo Data

Mar 6, 2017 09:25AM

Feb 10, 2017 06:31AM

Jan 9, 2017 06:54AM

Nov 29, 2016 06:42AM

Sep 29, 2016 06:29AM

Aug 16, 2016 08:34AM

Jul 20, 2016 06:54AM Vertex Pharma (VRTX) Doc Survey Shows Better Reimbursement for Orkambi - Baird

Apr 28, 2016 07:45AM

Oct 29, 2015 06:58AM

Oct 27, 2015 09:24AM

Jul 6, 2015 06:59AM

May 12, 2015 04:01PM

May 8, 2015 12:29PM

Mar 23, 2015 12:16PM Streetinsider.com's Hot Lunchtime Reads 3/23: (MCD) (MGM) (WU) (BIIB) (MCD)

Mar 23, 2015 12:11PM

Dec 24, 2014 07:51AM

Oct 13, 2014 06:34AM

Jun 24, 2014 05:28PM

Jun 24, 2014 01:03PM

Apr 25, 2014 07:33AM

Feb 7, 2013 09:24AM Baird Starts Vertex (VRTX) at Outperform

Nov 28, 2012 10:45AM

Nov 2, 2012 10:49AM

May 14, 2012 01:55PM

May 8, 2012 11:02AM

Feb 17, 2012 09:13AM

Nov 8, 2011 07:13AM

Oct 21, 2011 07:21AM Baird maintains an 'Outperform' on Vertex (VRTX); Building a Franchise Around Incivek; Pipeline Looks Like A Call Option

Aug 10, 2011 09:28AM

May 26, 2011 11:15AM

Feb 23, 2011 10:28AM

Dec 10, 2010 11:00AM

Aug 4, 2008 10:46AM

Apr 1, 2008 07:44AM

Jan 15, 2008 08:38AM Baird Initiates Coverage on Vertex Pharma (VRTX) with a Neutral

28,071 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All